Comparative efficacy of 'specific' potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity

G. M. Preminger, J. A. Harvey, C. Y C Pak

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

It is generally believed that conservative measures of high fluid intake and dietary modification in the setting of a stone clinic could favorably influence the course of renal stone disease. To establish the effect of specific medical treatment from the stone clinic effect, we compared the results of potassium citrate therapy to those of 11 reported conservative or placebo trials. The 54 patients receiving potassium citrate chosen for this comparison had mild to moderately severe stone disease (less than 1 stone per patient per year), similar to that encountered in conservative placebo trials (mean 0.54 stones per patient per year). New stone formation was virtually eliminated by potassium citrate therapy (a decrease from 0.52 to 0.02 stones per patient per year, a remission rate of 96%, p < 0.001), whereas it continued in 39% of the patients during conservative or placebo trials. However, in patients participating in conservative or placebo trials new stone formation decreased by only 54% (from 0.54 to 0.25 stones per patient per year). The superior response to potassium citrate suggested that this specific medical treatment exerted an additional favorable effect on the course of stone disease above the stone clinic effect.

Original languageEnglish (US)
Pages (from-to)658-661
Number of pages4
JournalJournal of Urology
Volume134
Issue number4
StatePublished - 1985

Fingerprint

Potassium Citrate
Nephrolithiasis
Placebos
Therapeutics
Diet Therapy
Conservative Treatment
Kidney

ASJC Scopus subject areas

  • Urology

Cite this

Comparative efficacy of 'specific' potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity. / Preminger, G. M.; Harvey, J. A.; Pak, C. Y C.

In: Journal of Urology, Vol. 134, No. 4, 1985, p. 658-661.

Research output: Contribution to journalArticle

@article{75a0b515b2274170a1fa7fa42ad2e4dd,
title = "Comparative efficacy of 'specific' potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity",
abstract = "It is generally believed that conservative measures of high fluid intake and dietary modification in the setting of a stone clinic could favorably influence the course of renal stone disease. To establish the effect of specific medical treatment from the stone clinic effect, we compared the results of potassium citrate therapy to those of 11 reported conservative or placebo trials. The 54 patients receiving potassium citrate chosen for this comparison had mild to moderately severe stone disease (less than 1 stone per patient per year), similar to that encountered in conservative placebo trials (mean 0.54 stones per patient per year). New stone formation was virtually eliminated by potassium citrate therapy (a decrease from 0.52 to 0.02 stones per patient per year, a remission rate of 96{\%}, p < 0.001), whereas it continued in 39{\%} of the patients during conservative or placebo trials. However, in patients participating in conservative or placebo trials new stone formation decreased by only 54{\%} (from 0.54 to 0.25 stones per patient per year). The superior response to potassium citrate suggested that this specific medical treatment exerted an additional favorable effect on the course of stone disease above the stone clinic effect.",
author = "Preminger, {G. M.} and Harvey, {J. A.} and Pak, {C. Y C}",
year = "1985",
language = "English (US)",
volume = "134",
pages = "658--661",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Comparative efficacy of 'specific' potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity

AU - Preminger, G. M.

AU - Harvey, J. A.

AU - Pak, C. Y C

PY - 1985

Y1 - 1985

N2 - It is generally believed that conservative measures of high fluid intake and dietary modification in the setting of a stone clinic could favorably influence the course of renal stone disease. To establish the effect of specific medical treatment from the stone clinic effect, we compared the results of potassium citrate therapy to those of 11 reported conservative or placebo trials. The 54 patients receiving potassium citrate chosen for this comparison had mild to moderately severe stone disease (less than 1 stone per patient per year), similar to that encountered in conservative placebo trials (mean 0.54 stones per patient per year). New stone formation was virtually eliminated by potassium citrate therapy (a decrease from 0.52 to 0.02 stones per patient per year, a remission rate of 96%, p < 0.001), whereas it continued in 39% of the patients during conservative or placebo trials. However, in patients participating in conservative or placebo trials new stone formation decreased by only 54% (from 0.54 to 0.25 stones per patient per year). The superior response to potassium citrate suggested that this specific medical treatment exerted an additional favorable effect on the course of stone disease above the stone clinic effect.

AB - It is generally believed that conservative measures of high fluid intake and dietary modification in the setting of a stone clinic could favorably influence the course of renal stone disease. To establish the effect of specific medical treatment from the stone clinic effect, we compared the results of potassium citrate therapy to those of 11 reported conservative or placebo trials. The 54 patients receiving potassium citrate chosen for this comparison had mild to moderately severe stone disease (less than 1 stone per patient per year), similar to that encountered in conservative placebo trials (mean 0.54 stones per patient per year). New stone formation was virtually eliminated by potassium citrate therapy (a decrease from 0.52 to 0.02 stones per patient per year, a remission rate of 96%, p < 0.001), whereas it continued in 39% of the patients during conservative or placebo trials. However, in patients participating in conservative or placebo trials new stone formation decreased by only 54% (from 0.54 to 0.25 stones per patient per year). The superior response to potassium citrate suggested that this specific medical treatment exerted an additional favorable effect on the course of stone disease above the stone clinic effect.

UR - http://www.scopus.com/inward/record.url?scp=0022359106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022359106&partnerID=8YFLogxK

M3 - Article

C2 - 3897582

AN - SCOPUS:0022359106

VL - 134

SP - 658

EP - 661

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -